Effective recruitment of participants to a phase I study using the internet and publicity releases through charities and patient organisations: analysis of the adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D)

BACKGROUND: A barrier to the successful development of new disease treatments is the timely recruitment of participants to experimental medicine studies that are primarily designed to investigate biological mechanisms rather than evaluate clinical efficacy. The aim of this study was to analyse the p...

Descripción completa

Detalles Bibliográficos

Autores principales:	Heywood, James, Evangelou, Marina, Goymer, Donna, Kennet, Jane, Anselmiova, Katerina, Guy, Catherine, O’Brien, Criona, Nutland, Sarah, Brown, Judy, Walker, Neil M, Todd, John A, Waldron-Lynch, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369347/ https://www.ncbi.nlm.nih.gov/pubmed/25881192 http://dx.doi.org/10.1186/s13063-015-0583-7